312 related articles for article (PubMed ID: 26829565)
1. Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.
Ceolin L; Romitti M; Siqueira DR; Vaz Ferreira C; Oliboni Scapineli J; Assis-Brazil B; Vieira Maximiano R; Dias Amarante T; de Souza Nunes MC; Weber G; Maia AL
PLoS One; 2016; 11(2):e0147840. PubMed ID: 26829565
[TBL] [Abstract][Full Text] [Related]
2. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
Ceolin L; Siqueira DR; Ferreira CV; Romitti M; Maia SC; Leiria L; Crispim D; Ashton-Prolla P; Maia AL
Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.
Zhang Y; Wang S; Chen X; Huang S; Li J
Tumour Biol; 2014 Jul; 35(7):6641-7. PubMed ID: 24699996
[TBL] [Abstract][Full Text] [Related]
6. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
[TBL] [Abstract][Full Text] [Related]
7. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
[TBL] [Abstract][Full Text] [Related]
8. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
Gursoy A; Erdogan MF; Erdogan G
J Endocrinol Invest; 2006 Nov; 29(10):858-62. PubMed ID: 17185892
[TBL] [Abstract][Full Text] [Related]
9. [G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].
Wohllk G N; Soto C E; Bravo A M; Becker C P
Rev Med Chil; 2005 Apr; 133(4):397-402. PubMed ID: 15953945
[TBL] [Abstract][Full Text] [Related]
10.
Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
[No Abstract] [Full Text] [Related]
11. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
12. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
Wang S; Wang B; Xie C; Ye D
Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.
Tamanaha R; Camacho CP; Pereira AC; da Silva AM; Maciel RM; Cerutti JM
Clin Endocrinol (Oxf); 2009 Jul; 71(1):56-64. PubMed ID: 19138318
[TBL] [Abstract][Full Text] [Related]
14. A common variant located in the 3'UTR of the RET gene is associated with protection from Hirschsprung disease.
Griseri P; Lantieri F; Puppo F; Bachetti T; Di Duca M; Ravazzolo R; Ceccherini I
Hum Mutat; 2007 Feb; 28(2):168-76. PubMed ID: 16986122
[TBL] [Abstract][Full Text] [Related]
15. Significance of 3'UTR and Pathogenic Haplotype in Glucose-6-Phosphate Deficiency.
Chaowanathikhom M; Nuchnoi P; Palasuwan D
Lab Med; 2017 Feb; 48(1):73-88. PubMed ID: 28138089
[TBL] [Abstract][Full Text] [Related]
16. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
Fernández RM; Peciña A; Antiñolo G; Navarro E; Borrego S
Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.
Silva AL; Carmo F; Moura MM; Domingues R; Espadinha C; Leite V; Cavaco B; Bugalho MJ
Endocrine; 2015 Jun; 49(2):366-72. PubMed ID: 25725622
[TBL] [Abstract][Full Text] [Related]
18. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
[TBL] [Abstract][Full Text] [Related]
19. Variability in Medullary Thyroid Carcinoma in
Mathiesen JS; Nielsen SG; Rasmussen ÅK; Kiss K; Wadt K; Hermann AP; Nielsen MF; Larsen SR; Brusgaard K; Frederiksen AL; Godballe C; Rossing M
Front Endocrinol (Lausanne); 2020; 11():251. PubMed ID: 32411094
[No Abstract] [Full Text] [Related]
20. Role of RET genetic variants in MEN2-associated pheochromocytoma.
Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]